144 related articles for article (PubMed ID: 15754040)
21. Green tea polyphenols as a natural tumour cell proteasome inhibitor.
Dou QP; Landis-Piwowar KR; Chen D; Huo C; Wan SB; Chan TH
Inflammopharmacology; 2008 Oct; 16(5):208-12. PubMed ID: 18815743
[TBL] [Abstract][Full Text] [Related]
22. Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro.
Zhang LC; Yu HN; Sun SL; Yang JG; He GQ; Ruan H; Shen SR
Toxicol In Vitro; 2008 Jun; 22(4):953-60. PubMed ID: 18359184
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
24. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
Sadava D; Whitlock E; Kane SE
Biochem Biophys Res Commun; 2007 Aug; 360(1):233-7. PubMed ID: 17585882
[TBL] [Abstract][Full Text] [Related]
25. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
Nakazato T; Ito K; Ikeda Y; Kizaki M
Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of gap junctional intercellular communication by the green tea polyphenol (-)-epigallocatechin gallate in normal rat liver epithelial cells.
Kang NJ; Lee KM; Kim JH; Lee BK; Kwon JY; Lee KW; Lee HJ
J Agric Food Chem; 2008 Nov; 56(21):10422-7. PubMed ID: 18828601
[TBL] [Abstract][Full Text] [Related]
27. Molecular targets for the cancer preventive activity of tea polyphenols.
Yang CS; Lambert JD; Hou Z; Ju J; Lu G; Hao X
Mol Carcinog; 2006 Jun; 45(6):431-5. PubMed ID: 16652355
[TBL] [Abstract][Full Text] [Related]
28. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
Khan N; Afaq F; Saleem M; Ahmad N; Mukhtar H
Cancer Res; 2006 Mar; 66(5):2500-5. PubMed ID: 16510563
[TBL] [Abstract][Full Text] [Related]
29. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
30. Green tea polyphenol (-) -epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection.
Kalfon L; Youdim MB; Mandel SA
J Neurochem; 2007 Feb; 100(4):992-1002. PubMed ID: 17156130
[TBL] [Abstract][Full Text] [Related]
31. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
[TBL] [Abstract][Full Text] [Related]
32. A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer.
Osanai K; Landis-Piwowar KR; Dou QP; Chan TH
Bioorg Med Chem; 2007 Aug; 15(15):5076-82. PubMed ID: 17544279
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression.
Wang X; Hao MW; Dong K; Lin F; Ren JH; Zhang HZ
Arch Pharm Res; 2009 Sep; 32(9):1263-9. PubMed ID: 19784583
[TBL] [Abstract][Full Text] [Related]
34. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
Stuart EC; Scandlyn MJ; Rosengren RJ
Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
[TBL] [Abstract][Full Text] [Related]
37. Prodrugs of fluoro-substituted benzoates of EGC as tumor cellular proteasome inhibitors and apoptosis inducers.
Yu Z; Qin XL; Gu YY; Chen D; Cui QC; Jiang T; Wan SB; Dou QP
Int J Mol Sci; 2008 Jun; 9(6):951-961. PubMed ID: 19325839
[TBL] [Abstract][Full Text] [Related]
38. (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway.
Wu PP; Kuo SC; Huang WW; Yang JS; Lai KC; Chen HJ; Lin KL; Chiu YJ; Huang LJ; Chung JG
Anticancer Res; 2009 Apr; 29(4):1435-42. PubMed ID: 19414399
[TBL] [Abstract][Full Text] [Related]
39. Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
Ahmed RS; Liu G; Renzetti A; Farshi P; Yang H; Soave C; Saed G; El-Ghoneimy AA; El-Banna HA; Foldes R; Chan TH; Dou QP
J Cell Biochem; 2016 Oct; 117(10):2357-69. PubMed ID: 26950525
[TBL] [Abstract][Full Text] [Related]
40. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.
Lambert JD; Sang S; Hong J; Kwon SJ; Lee MJ; Ho CT; Yang CS
Drug Metab Dispos; 2006 Dec; 34(12):2111-6. PubMed ID: 16997910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
